Medical Forge
Glycanostics was selected as one of eight most innovative companies to participate in the MEDICAL FORGE Accelerator program 2023, which will facilitate and accelerate our entry to the German market. We are looking forward to bring our innovation to the patients, healthcare professionals and healthcare system in Germany very soon!
EIC Summit, Brussels
Glycanostics was invited to attend the EIC Summit that took place on 7th and 8th December in Brussels. We have spent two days learning about the vision of the EIC and all the support that EIC offers to us with the aim to implement 5 NEIA Flagships & 25 Coalition of the Willing Initiatives to […]
EIC Corporate Day with Medtronic and Fresenius Kabi
Glycanostics was honoured to be invited for the EIC Corporate Day with Medtronic and Fresenius Kabi in November 2022. We presented our innovative approach to cancer diagnostics and had very interesting discussions on potential collaboration with these companies.
Diplomatic visit
Glycanostics, Ltd. hosted an important visit – 17 ambassadors from different countries from Asia, Europe, South America and USA. We introduced them our company, explained the challenges of current cancer diagnostics and healthcare systems and even tried some experiments together. Thanks to the Ministry of Foreign and European Affairs and state secretary Mrs. Ingrid Brocková for […]
Bio Europe Leipzig
Europe’s largest biotech partnering conference Bio Europe brings together key players in biotech industry, key decision-makers, most innovative companies and Glycanostics was among them. We established several useful contacts and discussed potential collaborations.
Start-up WorldCup awards
Glycanostics, Ltd. as a regional winner, was selected from more than 10 000 start-ups around the world to attend and compete at Startup World Cup 2022 in San Francisco.
Health Procurement Summit
Glycanostics was invited to attend 1st Pan-European Hospital and Healthcare Procurement Summit in Brussels as a recipient of EIC Accelerator grant. We presented our solutions for early cancer diagnostics, monitoring and screening in the upcoming years. We enjoyed discussions with numerous representatives of hospitals, health insurance companies and health procurement associations from various EU member states. […]
Enrich in the USA
Glycanostics, Ltd. is one of the three winners of the ENRICH in the USA (European Network of Research and Innovation Centres and Hubs) funding summit – Slovakia day. We are looking forward to our virtual and later hopefully physical landing in the US market to bring our revolutionary product in cancer diagnostics to the patients as […]
ISO 9001:2015 Certificate
We have been awarded the ISO 9001:2015 certificate in Research and Development of In-vitro Diagnostics Medical Devices.
